Department of Oral and Maxillofacial Surgery, King's Dental Institute,
London SE5 9RW
1
Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, Middlesex HA7
4LP, UK
2
Norfolk and Norwich Hospital, Brunswick Road, Norwich, Norfolk NR1 3SR,
UK
Correspondence to: M Heliotis, Department of Oral and Maxillofacial Surgery, King's Dental Institute, Caldecot Road, Camberwell, London SE5 9RW, UK E-mail: chacma{at}globalnet.co.uk
The presence of two rare conditions in a single patientbilateral osteonecrosis of the tarsal bones and glioblastoma multiforme of the brainraises the possibility of a causal association.
CASE HISTORY
A woman of 55 reported pain in both ankles for three months. There was no history of trauma or vascular disease and she had not taken any prescription medication for several years. Nothing abnormal was found on general physical examination. The ankle and hindfoot had diffuse discomfort, without swelling or increase in temperature. Ankle, hindfoot, and midfoot movements were normal. Blood analyses including haematological, rheumatological, and bone screening were unremarkable. Bilateral plain radiographs of the hands and the ankles were normal. A bone scan demonstrated focal areas of increased uptake in the tarsal bones bilaterally. A magnetic resonance imaging (MRI) scan of the feet revealed bone oedema in the right medial cuneiform and left navicular bones consistent with ischaemic necrosis. A biopsy specimen from the left navicular bone, taken under fluoroscopic control, showed no organisms or crystals and no bacterial growth was obtained on culture. Histopathological examination demonstrated thickened bony trabeculae with evidence of remodelling in the past, but the process appeared inactive.
The patient was diagnosed as having avascular necrosis of the right medial cuneiform and left navicular bones and was treated for six weeks with a left below-knee non-weight-bearing fibreglass cast.
Five months later she developed headaches with dizziness, and soon afterwards she was admitted with a Glasgow coma score of 5. Computerized tomography revealed a heterogeneous lesion in the right frontal lobe with a marked midline shift and contralateral ventricular dilatation. She underwent a right frontal lobectomy and the histopathological diagnosis was glioblastoma multiforme WHO grade IV. She subsequently received postoperative radical radiotherapy but died after about three months.
COMMENT
Avascular necrosis of the navicular bone may have no apparent cause or be
secondary to trauma or an underlying medical
condition1. In
almost all cases with an underlying medical disorder the lesion is bilateral;
many patients give a history of chronic steroid
use1. Avascular
necrosis is believed to arise from disruption to the microvasculature of the
bone2,3,
with resultant
infarction3.
Corticosteroid therapy, familial thrombophilia, hyperlipidaemia and tissue
factor release (from inflammatory bowel disease, malignancy) all predispose to
avascular
necrosis2,3,
and cytokines such as tumour necrosis factor
and transforming growth
factor ß
(TGF-ß)5 have
been proposed as mediators by inhibiting angiogenesis.
Several cytokines and their receptors have been identified as important in glioblastoma multiforme, among which TGF-ß is pivotal6. In normal glial cells it functions as an autocrine factor, inhibiting cell proliferation, differentiation and matrix synthesis7. It also inhibits the growth of endothelial cells, activates coagulation and inhibits fibrinolysis8. By contrast, in glioblastomas and other central nervous system tumours TGF-ß acts as a progression factor and mitogen6. We suggest that, in the case reported here, TGF-ß, released by the glioma, could have caused the avascular necrosis through its antiangiogenic and prothrombotic effects. Why involvement of the tarsus and not some other bone? This may reflect the specificity of TGF-ß for particular extracellular matrices7.
REFERENCES
This article has been cited by other articles:
![]() |
E. Tsiridis, E. M. Tsapakis, M. Heliotis, S. T. Donell, and D. G. Scott Commentary re T. Morimoto et al., Increased Levels of Tissue Endostatin in Human Malignant Gliomas. Clin. Cancer Res., 8: 2933-2938, 2002. Clin. Cancer Res., January 1, 2004; 10(1): 324 - 325. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||